Bpifrance

Poppins is a developer of digital therapeutic technology aimed at enhancing cognitive function in children with learning disorders. The company creates interactive musical games that integrate neurologic music therapy methods to address conditions such as dyslexia, dysphasia, and dyspraxia. These games focus on improving essential skills like concentration, motor skills, and memory through engaging activities that can be performed at home. By leveraging data science and advanced technologies, Poppins interprets learning, language, and motor performance to generate a cognitive score, facilitating personalized treatment plans. The company's mission is to provide accessible digital solutions for children facing learning challenges, ultimately aiming to improve their reading abilities and memory retention while supporting speech therapy.

SUPERBRANCHE is a biotechnology company focused on the early detection and treatment of metastases using advanced nanotechnology. The company develops therapeutic and diagnostic applications that aim to enhance accessibility and facilitate the timely identification of tumors. Its innovative platform incorporates targeted diagnostic and image-guided therapy nanomaterials, grounded in proprietary technology. This approach enables healthcare providers to detect and address metastases earlier, ultimately improving patient outcomes.

Vetbiolix is a veterinary biotechnology company dedicated to developing innovative therapeutic solutions for dogs and cats. The company focuses on creating first-in-class drug candidates aimed at treating and preventing diseases that affect pets, particularly in areas such as periodontitis, osteoarthritis, and gut motility disorders. By emphasizing clinical development, Vetbiolix strives to offer effective treatments for common health issues in pets, ultimately enhancing their quality of life.

Doado is a health technology company that specializes in developing mobile applications for back health management. Its primary product is an e-health application designed to guide users step by step in improving their back health and preventing Musculoskeletal Disorders. The application offers personalized video programs, expert advice from physiotherapists and doctors, and AI-driven progress tracking, enabling individuals and companies to maintain an active lifestyle and reduce the risk of chronic back pain.

Okomera is a biotech start-up focused on enhancing the development of precision-based cancer medicines. The company specializes in automating and streamlining individualized tumor biopsy research through innovative medical technologies. By utilizing microfluidic 3D cellular assays, Okomera's approach allows for the prediction of patient-specific responses to therapies. This is achieved by cultivating cells within thousands of microfluidic droplets and exposing them to various conditions in parallel, which accelerates the process of biologically relevant biopsy testing. Consequently, Okomera's technologies enable healthcare providers to expedite cancer treatment, ultimately improving patient outcomes.

Vetbiolix is a veterinary biotechnology company dedicated to developing innovative therapeutic solutions for dogs and cats. The company focuses on creating first-in-class drug candidates aimed at treating and preventing diseases that affect pets, particularly in areas such as periodontitis, osteoarthritis, and gut motility disorders. By emphasizing clinical development, Vetbiolix strives to offer effective treatments for common health issues in pets, ultimately enhancing their quality of life.

Enalees is a biotechnology company focused on developing molecular diagnostic tests specifically for pets. The company has created a platform that enables veterinarians to quickly identify microbes responsible for infectious diseases in leisure animals, such as horses. By providing DNA tests that can detect infections, Enalees facilitates timely diagnosis in veterinary clinics, allowing for more effective treatment of animal pathologies. This innovative approach aims to enhance the veterinary diagnostic process and improve animal health outcomes.

Archeon is focused on creating innovative solutions for the monitoring, diagnosis, and treatment of critically ill patients in prehospital care. The company develops artificial intelligence-based technologies aimed at enhancing ventilation quality in emergency medical services. Its products are designed to be practical, user-friendly, and intuitive for emergency caregivers, providing real-time feedback on the quality of ventilation administered to patients. This approach aims to improve patient outcomes and support medical professionals in high-pressure situations.

UroMems is a company dedicated to addressing specific clinical needs related to patient care, particularly in the area of urology. It develops implantable medical devices aimed at enhancing existing surgical treatments, thereby improving patient outcomes and reducing side effects. By focusing on innovative solutions, UroMems seeks to ensure that more patients can access effective treatments quickly, ultimately aiming to enhance their quality of life. The company is committed to the design, development, and commercialization of these active implantable devices, which reflect a deep understanding of the challenges faced by patients.

Ray Studios is a Tattoo removal studio that employs hydraulic acoustic wave technology in its "Le Ray Spark" Tattoo removal treatment device.

Klineo operates a digital platform that simplifies and enhances access to clinical trials for oncology patients and healthcare professionals. The platform offers two user interfaces, one for patients and one for doctors, enabling them to search for and connect with relevant clinical trials, particularly for breast, skin, and lymphoma conditions.

Pixacare is a company that develops a medical imaging application aimed at enhancing wound care management for healthcare professionals. This secure and collaborative platform automates medical photo management and centralizes essential data for monitoring wounds, making it user-friendly on both mobile and desktop devices. The application is a Class I CE-marked digital medical device that integrates seamlessly with existing healthcare infrastructures, including Patient Administration Systems and Electronic Health Records, ensuring interoperability. By transforming any smartphone camera into a secure documentation tool, Pixacare enables home-care staff, surgeons, and dermatologists to monitor and anticipate complications in chronic and post-surgery wounds. This innovation allows healthcare professionals to optimize their activities and save time in visual specialties while ensuring data security through hosting on certified Health Data Hosting servers.

Tribun Health is a company focused on transforming cancer detection through innovative diagnostic imaging software. Its solutions enable diagnostic laboratories and the pharmaceutical and biotech sectors to effectively manage, analyze, and share cellular images. By offering digital microscopy-like analysis along with macroscopic imaging capabilities, Tribun Health enhances the accuracy of diagnostics and scientific evaluations related to patient cells and tissues. The company's technology aims to streamline the workflow in laboratories, facilitating better collaboration and data sharing among healthcare professionals.

Metyos is a Paris-based company specializing in wearable biosensor technology that monitors the effects of daily activities on nutrition and metabolism. By analyzing individual data, such as fat levels and energy metabolism dynamics, Metyos provides users with personalized fitness and nutrition plans. Their aim is to help individuals understand how their bodies respond to various actions, enabling them to make informed choices and effectively work towards their weight goals. Through this innovative approach, Metyos empowers users to regain control over their health and wellness.

HawkCell is a medical research company specializing in advanced magnetic resonance imaging (MRI) solutions for veterinary clinics and preclinical research laboratories. The company utilizes a non-ionizing three-dimensional (3D) imaging approach, employing specialized MRI sensors designed to accommodate various animal morphologies. By adapting human MRI technology for animal diagnostics, HawkCell provides sustainable systems enhanced with artificial intelligence algorithms. This innovation allows veterinary clinics and research labs to obtain precise and insightful imaging, facilitating improved animal healthcare and scientific exploration.

Bioptimus specializes in the development of a universal artificial intelligence foundation model aimed at enhancing scientific research and biotechnological innovation. The company's technology seamlessly connects various scales of biology, ranging from molecules to cells, tissues, and entire organisms. By transforming multiscale data into actionable representations, Bioptimus enables its clients to drive breakthrough discoveries and accelerate advancements in the biomedical field.

Okomera is a biotech start-up focused on enhancing the development of precision-based cancer medicines. The company specializes in automating and streamlining individualized tumor biopsy research through innovative medical technologies. By utilizing microfluidic 3D cellular assays, Okomera's approach allows for the prediction of patient-specific responses to therapies. This is achieved by cultivating cells within thousands of microfluidic droplets and exposing them to various conditions in parallel, which accelerates the process of biologically relevant biopsy testing. Consequently, Okomera's technologies enable healthcare providers to expedite cancer treatment, ultimately improving patient outcomes.

Huvy specializes in developing a skin cancer screening application that utilizes artificial intelligence to enhance dermatological treatment pathways. The application aims to identify cancer risks and provide essential medical information in real-time. By facilitating dermatological screening, Huvy's technology enables access to initial diagnostic orientation for populations in areas with limited medical resources. This approach allows for timely care and intervention when there is a suspicion of skin cancer, ultimately improving health outcomes for underserved communities.

Steto Its mission is to create solutions for remote patient monitoring and digital diabetes therapies.

Poppins is a developer of digital therapeutic technology aimed at enhancing cognitive function in children with learning disorders. The company creates interactive musical games that integrate neurologic music therapy methods to address conditions such as dyslexia, dysphasia, and dyspraxia. These games focus on improving essential skills like concentration, motor skills, and memory through engaging activities that can be performed at home. By leveraging data science and advanced technologies, Poppins interprets learning, language, and motor performance to generate a cognitive score, facilitating personalized treatment plans. The company's mission is to provide accessible digital solutions for children facing learning challenges, ultimately aiming to improve their reading abilities and memory retention while supporting speech therapy.

Diamidex SAS, established in 2014 and based in Marseille, France, specializes in the development and production of rapid detection tests for legionella, a type of bacteria that can cause severe lung infections. The company offers turnkey test solutions, designed for both laboratory and field use, which provide a semi-quantitative count of microorganisms in water samples and industrial goods. Diamidex's products aim to enhance the accuracy of microbial contamination detection, facilitating quicker experimentation and data collection in research labs.

Nonna Lab is a company that specializes in the production of anti-hangover drinks designed to alleviate the symptoms of hangovers. Their products are formulated using vegan, low-sugar, and all-natural ingredients, ensuring a healthier option for consumers. The drinks are engineered to be quickly absorbed by the body's tissues and membranes, allowing individuals to recover more effectively after social events. By providing a solution that enables users to enjoy gatherings without the concern of negative aftereffects, Nonna Lab aims to enhance the overall experience of socializing.

Tribun Health is a company focused on transforming cancer detection through innovative diagnostic imaging software. Its solutions enable diagnostic laboratories and the pharmaceutical and biotech sectors to effectively manage, analyze, and share cellular images. By offering digital microscopy-like analysis along with macroscopic imaging capabilities, Tribun Health enhances the accuracy of diagnostics and scientific evaluations related to patient cells and tissues. The company's technology aims to streamline the workflow in laboratories, facilitating better collaboration and data sharing among healthcare professionals.

BioMAdvanced Diagnostics focuses on developing molecular diagnostic and biomarker tests that enhance patient care by integrating seamlessly into existing diagnostic and treatment protocols. The company's tests are designed to be user-friendly for healthcare personnel and economically accessible. By providing predictive scores and identifying biomarkers, these tests assist clinicians in evaluating and diagnosing the risk of transplant rejection, thereby enabling more effective and individualized treatment strategies. This approach aims to significantly improve patient outcomes by equipping physicians with advanced tools to monitor and manage their patients' immune responses.

Numa Health is a medical bioinformatics company that develops a digital health platform aimed at helping individuals optimize their health and well-being. The platform offers tools that reinterpret blood test results, providing users with insights into their body's functioning. By delivering accessible health information, Numa Health enables individuals to measure, understand, and take action regarding their health, fostering a greater commitment to personal health management.

CorWave is a developer of advanced implanted cardiac support devices aimed at improving the quality of life for patients with heart failure. The company's flagship product, an innovative left ventricular assist device (LVAD), employs a unique undulating disc wave pumping mechanism. This design enhances blood flow by mimicking the natural pulsation of the heart, significantly reducing trauma to blood and minimizing complications associated with clotting and bleeding, which are common with traditional continuous flow pumps. Additionally, CorWave's LVAD is characterized by low power consumption and compact size, making it suitable for complete implantation and integration with a wireless energy transfer system. Through its pioneering technology, CorWave seeks to alleviate the burdens of heart failure and lessen the need for invasive surgical interventions.

MOTEN Technologies specializes in muscle sensor technology and an analysis platform designed to prevent musculoskeletal disorders (MSDs) by measuring muscular effort. The company offers a range of services, including data processing, physical assistance, and analysis software. Their solutions enable decision-makers to optimize workstations and tasks for operators by monitoring body motion and associated muscular fatigue. By focusing on these areas, MOTEN Technologies aids companies in reducing the risks of MSDs, thereby promoting employee health and well-being.

Divie is a retail company that sells wellness products through its website. Their product categories such as drinks, oils, botanicals, herbal teas, isolates, plant oils, and infusions.

Valneva is a biopharmaceutical company specializing in the development, manufacturing, and distribution of prophylactic vaccines for infectious diseases. Its portfolio comprises two commercially available vaccines (IXIARO/JESPECT for Japanese encephalitis and DUKORAL for traveler's diarrhea), along with vaccine candidates targeting Lyme disease, chikungunya virus, and COVID-19. Valneva operates through segments including Commercialized Vaccines, Covid-19 Vaccine, Vaccine Candidates, and Technologies & Services. The company aims to address significant unmet medical needs in infectious diseases by leveraging its expertise and capabilities to advance vaccine candidates through clinical trials and ultimately commercialize them.

BioMAdvanced Diagnostics focuses on developing molecular diagnostic and biomarker tests that enhance patient care by integrating seamlessly into existing diagnostic and treatment protocols. The company's tests are designed to be user-friendly for healthcare personnel and economically accessible. By providing predictive scores and identifying biomarkers, these tests assist clinicians in evaluating and diagnosing the risk of transplant rejection, thereby enabling more effective and individualized treatment strategies. This approach aims to significantly improve patient outcomes by equipping physicians with advanced tools to monitor and manage their patients' immune responses.

Guerbet is a healthcare company focused on medical imaging, with a history spanning 90 years. As a pioneer in contrast media, it is the only pharmaceutical group dedicated exclusively to this field. Guerbet operates in nearly 80 countries through a network of subsidiaries and distributors, providing a wide array of products for various imaging modalities, including CT scans, magnetic resonance imaging (MRI), ultrasound, and nuclear medicine. The company’s portfolio includes well-known brands such as Xenetix, Optiray, Dotarem, and Telebrix, among others. Additionally, Guerbet offers injectors and related medical devices aimed at enhancing patient diagnosis, prognosis, and overall quality of life.

Incepto Medical SAS, established in 2018 and headquartered in Paris, France, specializes in developing and distributing artificial intelligence (AI) applications for medical imaging. The company's portfolio includes software solutions like Qure.ai qER for head CT analysis, Qure.ai qXR for thorax abnormality detection, Aidence Veye Chest for pulmonary nodule tracking, Icometric Icobrain for neurological disorder monitoring, and ScreenPoint Transpara for breast cancer detection. Additionally, Incepto operates Collective Minds Radiology, an online platform facilitating case support, opinion sharing, and learning among healthcare professionals. The company aims to empower healthcare professionals by providing AI-driven tools that help manage the increasing volume of patients and images, ultimately enhancing patient care.

Nurea develops a decision-making support solution specifically for healthcare professionals, particularly vascular surgeons. The company specializes in medical imaging software that automates image analysis, providing accurate quantitative assessments to aid in the diagnosis of vascular diseases. Its platform facilitates the management of patient groups during both pre- and post-operative monitoring through an automated workflow, which includes comprehensive full-body scan analysis. By offering decision indicators aimed at preventing cardiovascular incidents, Nurea simplifies the decision-making process for surgeons, enhancing patient care in the realm of cardiovascular health. An online inquiry form is available on their website for further information.

Sonio is an AI-based support platform for fetal ultrasound, helping practitioners analyze and diagnose congenital malformations. Sonio combines the patient’s medical history, genetic and biological data, and ultrasound semiology to assist physicians on the path to the right diagnosis. It assists sonographers during prenatal screening scans, helping them ensure that they have not forgotten anything, take risk factors into account, and facilitate the sharing of images with patients and other health professionals.

Implicity is a developer of a remote monitoring platform that specializes in the smart monitoring of patients with connected cardiac devices, such as pacemakers and defibrillators. The platform utilizes artificial intelligence to sort and summarize patient data, assessing the criticality of alerts based on individual medical contexts. This capability allows cardiologists and healthcare professionals to automate the monitoring process, enabling them to effectively oversee patient health while consolidating information on a single platform. By streamlining remote monitoring, Implicity aims to enhance the quality of care provided to patients with cardiac implants.

Istya is a company focused on developing solutions for monitoring, predicting, and managing indoor air quality. Founded in 2021 and headquartered in Ile-de-France, France, Istya offers air quality sensors that measure fine particles and provide real-time monitoring and predictive analysis tailored to specific indoor environments. Their eco-designed solutions aim to enhance air quality while also reducing the energy costs associated with ventilation systems. Additionally, Istya's technology helps mitigate the risk of virus transmission through the air, promoting a healthier indoor atmosphere for various settings.

Archeon is focused on creating innovative solutions for the monitoring, diagnosis, and treatment of critically ill patients in prehospital care. The company develops artificial intelligence-based technologies aimed at enhancing ventilation quality in emergency medical services. Its products are designed to be practical, user-friendly, and intuitive for emergency caregivers, providing real-time feedback on the quality of ventilation administered to patients. This approach aims to improve patient outcomes and support medical professionals in high-pressure situations.

NaoX Technologies is focused on preventing neurological disorders through innovative connected solutions. The company has developed wireless headphones equipped with integrated sensors that passively monitor brain activity by detecting brain vibrations. These headphones record electroencephalogram data in real time and aggregate the information on a software dashboard for healthcare professionals. By providing this technology, NaoX Technologies aims to democratize access to neurological disorder prevention and support patients in their recovery from mental health issues.

Heroic Sante is a virtual platform. They offer patients the chance to have their questions answered by qualified carers and learn from other patients. Their community works to create useful projects for patients and finances them thanks to statements on applications.

Core for Tech is a deep technology company focused on enhancing driver safety by measuring and predicting drowsiness while driving. Utilizing advanced technology that analyzes heart rate variability through native sensors or retrofit systems in vehicles, Core for Tech transforms this data into actionable insights about a driver's fatigue levels. By detecting drowsiness at an early stage, before it becomes visibly apparent, the company aims to provide timely information that enables drivers to make informed safety decisions. Through its innovative approach, Core for Tech seeks to contribute significantly to road safety and reduce the risks associated with driver fatigue.

Echoliv is a medical technology company specializing in artificial intelligence solutions for abdominal ultrasound. The company develops software designed to assist radiologists and hepatologists in early-stage screening for hepatocellular carcinoma, the most common type of liver cancer. Echoliv's flagship product, Ultraliv, employs advanced algorithms to identify nodules that may be overlooked by practitioners, enhancing diagnostic accuracy and improving patient care. By integrating AI into the ultrasound process, Echoliv aims to support healthcare professionals in delivering timely and effective treatment for liver cancer.

Provepharm Life Solutions SA is a life sciences company based in Marseille, France, specializing in contract research and development services for small molecules and therapeutic peptides. Founded in 1998, the company focuses on the development, manufacturing, and marketing of pharmaceutical products and active ingredients. A key offering is pharmacopoeial grade methylene blue, a versatile compound utilized in various human health applications, including as an antidote for methemoglobinemia, a mild urinary antiseptic, and a topical antiseptic. The company also addresses animal health needs, providing solutions for toxicosis and aquaculture. Methylene blue serves additional roles as a laboratory dye, indicator, and diagnostic aid in surgical procedures. Provepharm Life Solutions aims to lead in the life sciences sector through its innovative approach, known as Molecule Vitalization, and offers a range of research and manufacturing services to advance health solutions.

Pixyl is a developer of a neuroimaging cloud platform that enhances patient care for radiologists by providing critical decision-making information from neuroimaging data. Their platform, Pixyl.Neuro, utilizes advanced machine learning techniques to automatically analyze MRI images, offering detailed insights into brain structures such as grey matter, white matter, and intracranial volumes. This capability allows clinicians to extract neuroimaging biomarkers that improve decision-making in both clinical studies and routine practice, particularly in the context of multiple sclerosis, stroke, and neurodegenerative diseases. By integrating seamlessly into the workflows of imaging contract research organizations, neuroradiologists, and neurologists, Pixyl aims to facilitate data-driven and value-based patient care, ensuring that vital information is accessible to healthcare providers when it is most needed.

UroMems is a company dedicated to addressing specific clinical needs related to patient care, particularly in the area of urology. It develops implantable medical devices aimed at enhancing existing surgical treatments, thereby improving patient outcomes and reducing side effects. By focusing on innovative solutions, UroMems seeks to ensure that more patients can access effective treatments quickly, ultimately aiming to enhance their quality of life. The company is committed to the design, development, and commercialization of these active implantable devices, which reflect a deep understanding of the challenges faced by patients.

Poppins is a developer of digital therapeutic technology aimed at enhancing cognitive function in children with learning disorders. The company creates interactive musical games that integrate neurologic music therapy methods to address conditions such as dyslexia, dysphasia, and dyspraxia. These games focus on improving essential skills like concentration, motor skills, and memory through engaging activities that can be performed at home. By leveraging data science and advanced technologies, Poppins interprets learning, language, and motor performance to generate a cognitive score, facilitating personalized treatment plans. The company's mission is to provide accessible digital solutions for children facing learning challenges, ultimately aiming to improve their reading abilities and memory retention while supporting speech therapy.

OncoDiag is a French biotechnology company located in Normandy, dedicated to creating non-invasive diagnostic tests aimed at the early detection of cancers. Its flagship product, the Urotest, is a urine test approved for the diagnosis and monitoring of bladder cancer. In addition to the Urotest, OncoDiag is developing Colodiag, a test focused on the early identification of colorectal cancer, and other diagnostic tools, including a tissue-based test for predicting non-evolutive localized prostate cancer. Through its innovative testing kits, OncoDiag aims to enhance cancer diagnostics, allowing healthcare professionals to provide timely and effective patient care.

Omini is a French company, established in 2019 and based in Saint Mandé, that specializes in the development of portable and multipurpose bio-sensing devices for blood testing. The company’s biosensor platform allows for the simultaneous detection of multiple biomarkers, providing personalized blood biomarker data that can be utilized to tailor therapies and prevent acute crises in patients with chronic conditions. By employing advanced multiplex electrochemical biosensor technology, Omini's devices offer accurate and affordable solutions for identifying, analyzing, and monitoring various target biomarkers. This innovation supports decentralized testing and at-home monitoring, ultimately aiming to alleviate the burden on healthcare systems and improve patient outcomes. Omini primarily serves general practitioners, enhancing their ability to manage patient care effectively.

Grapheal is a Medtech startup focused on developing embedded and wearable biosensors that leverage graphene transistors for enhanced functionality. Their devices are designed to be minimalistic and digital, enabling the dosing of biomarkers and detection of pathogens through a smartphone interface. By integrating advanced sensing nanomaterials with wireless connectivity and data analysis capabilities, Grapheal's biosensors facilitate field diagnostics and remote patient monitoring. This approach aims to make healthcare more accessible and accurate, allowing medical professionals to effectively monitor patient progress and healing.

Apneal is a developer of a mobile app that provides a sleep diagnostics platform aimed at assessing sleep quality and diagnosing sleep apnea. By utilizing a smartphone's built-in sensors, including microphones, accelerometers, and gyroscopes, the app can monitor a patient's sleep patterns even in airplane mode, ensuring no electromagnetic interference occurs. The platform employs deep learning technology to transform smartphones into medical devices capable of automatically detecting cardio-respiratory events and analyzing sleep data through interpretable signals. Results are then communicated to healthcare providers via an ergonomic dashboard, allowing users to conduct sleep examinations conveniently without the need for cumbersome equipment or prolonged waiting times.

CorWave is a developer of advanced implanted cardiac support devices aimed at improving the quality of life for patients with heart failure. The company's flagship product, an innovative left ventricular assist device (LVAD), employs a unique undulating disc wave pumping mechanism. This design enhances blood flow by mimicking the natural pulsation of the heart, significantly reducing trauma to blood and minimizing complications associated with clotting and bleeding, which are common with traditional continuous flow pumps. Additionally, CorWave's LVAD is characterized by low power consumption and compact size, making it suitable for complete implantation and integration with a wireless energy transfer system. Through its pioneering technology, CorWave seeks to alleviate the burdens of heart failure and lessen the need for invasive surgical interventions.

Braintale is a Paris-based company founded in 2018 that develops and distributes diagnostic and prognostic tools specifically designed for brain-injured patients. Its platform focuses on analyzing MRI reports to assist healthcare professionals in effectively diagnosing patients who are in comas due to severe traumatic brain injuries, cardiac arrests, or hemorrhagic strokes. With over 15 years of clinical development backing its products, Braintale aims to meet the expectations of both healthcare professionals and patients by providing accessible and effective tools for prognosis and diagnosis in critical care settings.

Medaviz is an online platform founded in 2014 and headquartered in Paris, France, that facilitates immediate communication between patients and healthcare professionals. The service allows users to connect with various specialists, including general practitioners, pediatricians, gynecologists, and psychologists, at any time. By providing access to medical advice around the clock, Medaviz enables users to address their medical issues or emergencies efficiently, enhancing the convenience of healthcare access.

SideROS is a biotechnology company based in Paris, France, established in 2019. The company focuses on researching iron-targeting chemical compounds to develop drug candidates aimed at persister cancer cells, which are resistant to conventional treatments and linked to metastasis and relapse. One of its key developments is ironomycin, a chemical molecule that disrupts iron homeostasis in persister cancer cells, leading to cell death through a process known as ferroptosis. By targeting these resilient cancer cells, SideROS aims to advance cancer treatment options.

Withings is a developer of digital health and wellness smart devices aimed at empowering individuals to make informed health decisions. The company offers a diverse array of products, including smart scales that help users achieve fitness and weight goals, stylish activity trackers and hybrid smartwatches, and an advanced sleep-tracking mat. Additionally, Withings produces medically accurate devices for monitoring blood pressure and temperature, enabling users to track their health progress effectively. These devices facilitate data sharing with healthcare professionals, enhancing the overall management of personal health.

Synapse Medicine, founded in 2017 and based in Bordeaux, France, specializes in developing an online platform that supports healthcare professionals in managing drug prescriptions. The company's platform offers a comprehensive global knowledge base, utilizing algorithms to ensure the information is reliable and up-to-date. This service helps doctors and pharmacists access accurate medication data, enabling them to analyze treatments in real-time and enhance the safety of drug therapies. Synapse Medicine collaborates with leading hospitals and digital health companies across the United States, Europe, and Japan to transform medication management, aiming to improve overall medication success for patients.

UroMems is a company dedicated to addressing specific clinical needs related to patient care, particularly in the area of urology. It develops implantable medical devices aimed at enhancing existing surgical treatments, thereby improving patient outcomes and reducing side effects. By focusing on innovative solutions, UroMems seeks to ensure that more patients can access effective treatments quickly, ultimately aiming to enhance their quality of life. The company is committed to the design, development, and commercialization of these active implantable devices, which reflect a deep understanding of the challenges faced by patients.

UroMems is a company dedicated to addressing specific clinical needs related to patient care, particularly in the area of urology. It develops implantable medical devices aimed at enhancing existing surgical treatments, thereby improving patient outcomes and reducing side effects. By focusing on innovative solutions, UroMems seeks to ensure that more patients can access effective treatments quickly, ultimately aiming to enhance their quality of life. The company is committed to the design, development, and commercialization of these active implantable devices, which reflect a deep understanding of the challenges faced by patients.

Deinove SA is a biotechnology company based in Grabels, France, focused on discovering, developing, and producing microbial-derived compounds for the health, nutrition, and cosmetics sectors. The company is advancing its portfolio of antibiotic candidates, including DNV3837, which is currently undergoing Phase II clinical trials for treating Clostridioides difficile infections. In the cosmetics arena, Deinove offers various bioactive ingredients such as PHYT-N-Resist, Luminity, HEBELYS, and BIOME Oléoactif, which serve functions ranging from anti-aging to balancing skin microbiota. Additionally, Deinove is exploring processes for producing natural ingredients for animal feed. The company has established partnerships with several organizations, including bioMérieux and the Institut Pasteur, to enhance its research and development initiatives. Founded in 2006, Deinove is committed to leveraging its bacterial biodiversity to create sustainable solutions across multiple industries.

Cardiologs is a medical technology company founded in 2014 that focuses on enhancing cardiac diagnostics through the use of medical-grade artificial intelligence and cloud technology. The company's flagship product, the Cardiologs Holter solution, leverages a proprietary database of over 18 million recordings, underpinned by numerous clinical publications that affirm its diagnostic accuracy. Cardiologs aims to democratize access to expert cardiac care worldwide by providing healthcare practitioners with advanced tools for electrocardiogram interpretation and automatic heart disorder screening, thereby streamlining the diagnostic process and improving patient outcomes. Their innovative approach combines cutting-edge deep learning technology with a commitment to making high-quality cardiac diagnostics accessible to all.

Deeplink Medical develops a teleradiology platform aimed at enhancing telemedicine projects for healthcare professionals. Recognizing the limitations of existing telemedicine IT solutions, the company focuses on creating innovative tools that address real needs in the medical field. Their platform streamlines requests for imaging examinations, standardizes examination protocols, and ensures the secure transmission of essential data among healthcare providers. This approach allows users to operate independently in their teleradiology activities without reliance on a medical network. Additionally, Deeplink Medical emphasizes the importance of comprehensive support, training, and medical protocols to optimize patient management and ensure the success of telemedicine initiatives.

BioSerenity is a company focused on enhancing the understanding and treatment of epilepsy and other chronic diseases through innovative, digitally connected devices. These devices facilitate the retrieval and interpretation of electrophysiological signals, including electroencephalograms, electrocardiograms, and polysomnography. By enabling continuous remote monitoring of patients' health data, BioSerenity aims to optimize patient pathways in cardiology, neurology, and sleep disorders. The company also collaborates with the scientific community by providing anonymized data to researchers at the Institut du Cerveau et de la Moelle épinière (ICM), thereby contributing to advancements in epilepsy research and improving future diagnostic methods.

Neurallys is a Paris-based company specializing in the development and production of medical devices for neurology and neurosurgery. The company has created an intelligent sensor that communicates with a smartphone to monitor intracranial pressure in patients with hydrocephalus. This innovative device aims to enhance patient comfort and provide neurosurgeons with a valuable tool for more effective management and follow-up of the condition, ultimately improving the quality of care for those affected by hydrocephalus.

Deinove SA is a biotechnology company based in Grabels, France, focused on discovering, developing, and producing microbial-derived compounds for the health, nutrition, and cosmetics sectors. The company is advancing its portfolio of antibiotic candidates, including DNV3837, which is currently undergoing Phase II clinical trials for treating Clostridioides difficile infections. In the cosmetics arena, Deinove offers various bioactive ingredients such as PHYT-N-Resist, Luminity, HEBELYS, and BIOME Oléoactif, which serve functions ranging from anti-aging to balancing skin microbiota. Additionally, Deinove is exploring processes for producing natural ingredients for animal feed. The company has established partnerships with several organizations, including bioMérieux and the Institut Pasteur, to enhance its research and development initiatives. Founded in 2006, Deinove is committed to leveraging its bacterial biodiversity to create sustainable solutions across multiple industries.

Happytal, founded in 2013 and based in Vanves, France, specializes in concierge services for hospitals. The company aims to enhance the patient experience by providing a range of services designed to promote comfort during hospital stays. These services include personal care options such as hairdressing and beautician services, as well as practical amenities like newspaper delivery and meal baskets. Happytal focuses on integrating local products and services, allowing patients to maintain their daily habits while receiving care. By offering these conveniences, Happytal seeks to improve the overall atmosphere for patients and their families within healthcare facilities.

Foodvisor operates a nutrition application that helps users make healthier dietary choices by providing detailed nutritional information. The app leverages smartphone camera technology to identify food items on users' plates, estimate serving sizes, and generate comprehensive nutrition reports within seconds. By offering more than just calorie counting, Foodvisor aims to assist users in adopting better eating habits and achieving a balanced diet.

C4Diagnostics specializes in the development and commercialization of in vitro diagnostic (IVD) kits utilizing its proprietary technology. The company focuses on creating medical devices and equipment that enhance the speed and sensitivity of diagnostic tests. One of its primary offerings includes solutions for urinary tract infection screening, which reliably detects, counts, and concentrates culturable microorganisms relevant to clinical microbiology. This capability allows hospitals and laboratories to conduct culture-based IVD tests with improved accuracy and efficiency, contributing to better patient outcomes in diagnostic processes.

Core for Tech is a deep technology company focused on enhancing driver safety by measuring and predicting drowsiness while driving. Utilizing advanced technology that analyzes heart rate variability through native sensors or retrofit systems in vehicles, Core for Tech transforms this data into actionable insights about a driver's fatigue levels. By detecting drowsiness at an early stage, before it becomes visibly apparent, the company aims to provide timely information that enables drivers to make informed safety decisions. Through its innovative approach, Core for Tech seeks to contribute significantly to road safety and reduce the risks associated with driver fatigue.

RUBIX S&I SAS, founded in 2016 and headquartered in Toulouse, France, specializes in the development and provision of electronic monitoring devices and software solutions for analyzing air quality, noise, and odors. The company offers a range of products, including the WatchTower series and Rubix PoD, which facilitate real-time data collection and analytics concerning environmental nuisances and building performance. Additionally, Rubix Home is designed to monitor indoor air quality. These devices utilize various gas sensor arrays to assess emissions both indoors and outdoors. Founded by Jean-Christophe Mifsud, who has over two decades of experience in high-tech company development, RUBIX S&I is committed to enhancing safety and wellness in work environments through its innovative Internet of Things (IoT) solutions.

Core for Tech is a deep technology company focused on enhancing driver safety by measuring and predicting drowsiness while driving. Utilizing advanced technology that analyzes heart rate variability through native sensors or retrofit systems in vehicles, Core for Tech transforms this data into actionable insights about a driver's fatigue levels. By detecting drowsiness at an early stage, before it becomes visibly apparent, the company aims to provide timely information that enables drivers to make informed safety decisions. Through its innovative approach, Core for Tech seeks to contribute significantly to road safety and reduce the risks associated with driver fatigue.

Cardiologs is a medical technology company founded in 2014 that focuses on enhancing cardiac diagnostics through the use of medical-grade artificial intelligence and cloud technology. The company's flagship product, the Cardiologs Holter solution, leverages a proprietary database of over 18 million recordings, underpinned by numerous clinical publications that affirm its diagnostic accuracy. Cardiologs aims to democratize access to expert cardiac care worldwide by providing healthcare practitioners with advanced tools for electrocardiogram interpretation and automatic heart disorder screening, thereby streamlining the diagnostic process and improving patient outcomes. Their innovative approach combines cutting-edge deep learning technology with a commitment to making high-quality cardiac diagnostics accessible to all.

BioSerenity is a company focused on enhancing the understanding and treatment of epilepsy and other chronic diseases through innovative, digitally connected devices. These devices facilitate the retrieval and interpretation of electrophysiological signals, including electroencephalograms, electrocardiograms, and polysomnography. By enabling continuous remote monitoring of patients' health data, BioSerenity aims to optimize patient pathways in cardiology, neurology, and sleep disorders. The company also collaborates with the scientific community by providing anonymized data to researchers at the Institut du Cerveau et de la Moelle épinière (ICM), thereby contributing to advancements in epilepsy research and improving future diagnostic methods.

Wynd Technologies, Inc., established in 2014 and based in San Jose, California, specializes in manufacturing air purifiers for personal use and providing environmental monitoring services. The company offers the Wynd portable air purifier, which includes a removable sensor to monitor air quality and initiate purification. Additionally, Wynd Technologies provides real-time air quality measurement and monitoring services, such as Wynd Halo Pro, to ensure proper operation and maintenance of its products. The company also operates an online retail platform for its products.

UroMems is a company dedicated to addressing specific clinical needs related to patient care, particularly in the area of urology. It develops implantable medical devices aimed at enhancing existing surgical treatments, thereby improving patient outcomes and reducing side effects. By focusing on innovative solutions, UroMems seeks to ensure that more patients can access effective treatments quickly, ultimately aiming to enhance their quality of life. The company is committed to the design, development, and commercialization of these active implantable devices, which reflect a deep understanding of the challenges faced by patients.

CorWave is a developer of advanced implanted cardiac support devices aimed at improving the quality of life for patients with heart failure. The company's flagship product, an innovative left ventricular assist device (LVAD), employs a unique undulating disc wave pumping mechanism. This design enhances blood flow by mimicking the natural pulsation of the heart, significantly reducing trauma to blood and minimizing complications associated with clotting and bleeding, which are common with traditional continuous flow pumps. Additionally, CorWave's LVAD is characterized by low power consumption and compact size, making it suitable for complete implantation and integration with a wireless energy transfer system. Through its pioneering technology, CorWave seeks to alleviate the burdens of heart failure and lessen the need for invasive surgical interventions.

Omind Neurotechnologies specializes in neurotraining services and content, harnessing applied neuroscience and neurotechnology to enhance individual and team performance. The company offers a comprehensive platform that includes a normative multimodal database, virtual reality stimuli, and real-time multimodal signal processing through its TimeFlux technology. Additionally, Omind maintains an anonymized repository known as Quetzal for research and development purposes. With a team of experts, including nine Ph.D. holders, the organization focuses on creating effective training strategies that promote emotional management, decision-making, and overall efficiency in everyday life for its clients. Through its emphasis on collective intelligence and group resilience, Omind aims to improve team dynamics and personal development.

Cardiologs is a medical technology company founded in 2014 that focuses on enhancing cardiac diagnostics through the use of medical-grade artificial intelligence and cloud technology. The company's flagship product, the Cardiologs Holter solution, leverages a proprietary database of over 18 million recordings, underpinned by numerous clinical publications that affirm its diagnostic accuracy. Cardiologs aims to democratize access to expert cardiac care worldwide by providing healthcare practitioners with advanced tools for electrocardiogram interpretation and automatic heart disorder screening, thereby streamlining the diagnostic process and improving patient outcomes. Their innovative approach combines cutting-edge deep learning technology with a commitment to making high-quality cardiac diagnostics accessible to all.

Magnisense conçoit, développe et commercialise des tests de diagnostic d'urgence pour les maladies cardio-vasculaires à partir de sa technologie MIAtek® et de son instrument de diagnostic propriétaires

Theravectys is a biotechnology company focused on developing a novel vaccine platform aimed at treating and preventing a wide array of infectious diseases, cancers, and other medical conditions. The company’s innovative vaccination technology utilizes gene transfer into dendritic cells to modulate the immune response, enhancing the effectiveness of both prophylactic and therapeutic immunotherapies. Their lead product, a therapeutic vaccine targeting HIV/AIDS, has demonstrated promising efficacy and safety in non-human primate studies and is set to enter clinical trials. Through its diverse pipeline, Theravectys aims to provide healthcare providers with advanced treatment options that elicit a potent and targeted immune response in patients.

Voluntis, established in 2001, specializes in developing digital therapeutic solutions for diabetes, oncology, and other therapeutic areas. The company offers products such as Insulia, Diabeo, Oleena, and AstraZeneca, which provide automated insulin dose recommendations, patient-specific dosage suggestions, and management of side effects like hypertension and diarrhea. Voluntis collaborates with pharmaceutical companies like Bristol-Myers Squibb to co-develop digital therapeutics for oncology. Headquartered in France with operations in the U.S., Voluntis aims to enhance patient outcomes and healthcare system efficiency through innovative, secure, and patient-centric digital health solutions.

Skuldtech is specialized in the discovery of new Biomarkers and the development of Diagnostics focused on personalized medicine applications. This expertise enables the company to provide genomic, pharmacogenomic and transcriptomic services, as well as innovative diagnostics associated with new treatments, especially in cancer, neurodegenerative and infectious diseases.

Withings is a developer of digital health and wellness smart devices aimed at empowering individuals to make informed health decisions. The company offers a diverse array of products, including smart scales that help users achieve fitness and weight goals, stylish activity trackers and hybrid smartwatches, and an advanced sleep-tracking mat. Additionally, Withings produces medically accurate devices for monitoring blood pressure and temperature, enabling users to track their health progress effectively. These devices facilitate data sharing with healthcare professionals, enhancing the overall management of personal health.